Boehringer Ingelheim leader in hatchery vaccination with vector vaccines

Boehringer Ingelheim reaffirms its leading position in hatchery vaccination with its vector vaccines at IPPE 2019Vaxxitek ® HVT + IBD continues to lead in hatchery vector vaccination worldwideNewxxitek ® HVT + ND is Boehringer Ingelheim’s latest vectored vaccine against Newcastle disease

Source: Boehringer Ingelheim Corporate News - February 4, 2019 Category: Research Source Type: news